{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:56:58Z","timestamp":1790773018704,"version":"4.1.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Intrahepatic cholestasis of pregnancy (ICP; prevalence 0.2\u201315.6%) is the most common pregnancy-related liver disorder. It may have serious consequences for a pregnancy, including increased risk of preterm delivery, meconium staining of amniotic fluid, fetal bradycardia, distress, and fetal demise. In cases of high bile acids (&amp;gt;100\u03bcmol\/L), patients have 10-fold increase in the risk of stillbirth. Biophysical methods of fetal monitoring, such as cardiotocography, ultrasonography, or Doppler have been proven unreliable for risk prediction in the course of intrahepatic cholestasis. Therefore, we believe extensive research for more specific, especially early, markers should be carried out. By analogy with cholestasis in children with inherited alpha-1 antitrypsin deficiency (AATD), we hypothesized the <jats:italic>SERPINA1<\/jats:italic> Z pathogenic variant might be related to a higher risk of cholestasis in pregnancy. This study aimed to investigate the most common AATD variants (Z and S SERPINA1 alleles) in a group of cholestatic pregnant women.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The Z carrier frequency was calculated to be 6.8%, which is much higher compared to the general population [2.3%; the Chi-squared test with Yates correction is 6.8774 (<jats:italic>p<\/jats:italic>=0.008)].<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Increased prevalence of <jats:italic>SERPINA1<\/jats:italic> PI*Z variant in a group of women with intrahepatic cholestasis may suggest a possible genetic origin of a higher risk of intrahepatic cholestasis in pregnancy.<\/jats:p>","DOI":"10.3389\/fgene.2021.720465","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T14:39:37Z","timestamp":1631025577000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Alpha-1 Antitrypsin Z Variant (AAT PI*Z) as a Risk Factor for Intrahepatic Cholestasis of Pregnancy"],"prefix":"10.3389","volume":"12","author":[{"given":"Przemyslaw","family":"Kosinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Kedzia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianna","family":"Mostowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Gutaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Lipa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Wender-Ozegowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Rozy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Chorostowska-Wynimko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslaw","family":"Wielgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Jezela-Stanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1651-2227.1972.tb15960.x","article-title":"Neonatal cholestasis in alpha-1-antitrypsin deficient children. Clinical, genetic, histological and immunohistochemical findings","volume":"61","author":"Aagenaes","year":"1972","journal-title":"Acta Paediatr. Scand."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A protein-truncating HSD17B13 variant and protection from chronic liver disease","volume":"378","author":"Abul-Husn","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1001\/jama.2009.1295","article-title":"Genetic modifiers of liver disease in cystic fibrosis","volume":"302","author":"Bartlett","year":"2009","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejogrb.2018.10.041","article-title":"Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines","volume":"231","author":"Bicocca","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.15326\/jcopdf.7.3.2019.0148","article-title":"Alpha-1 antitrypsin deficiency-mediated liver toxicity: why do some patients do poorly? What do we know so far?","volume":"7","author":"Bouchecareilh","year":"2020","journal-title":"Chronic Obstr. Pulm. Dis."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"100.e101","DOI":"10.1016\/j.ajog.2014.07.026","article-title":"Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels","volume":"212","author":"Brouwers","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(19)31270-X","article-title":"Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial","volume":"394","author":"Chappell","year":"2019","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12929-018-0475-8","article-title":"Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases","volume":"25","author":"Chen","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"ref9","first-page":"319","article-title":"Incidence of alpha-1 antitrypsin Z and S alleles in patients with granulomatosis with polyangiitis\u2014pilot study","volume":"81","author":"Chorostowska-Wynimko","year":"2012","journal-title":"Pneumonol. Alergol. Pol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/MEG.0000000000001108","article-title":"Retrospective analysis of children with alpha-1 antitrypsin deficiency","volume":"30","author":"Comba","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/thoraxjnl-2011-201321","article-title":"Serum levels and genotype distribution of alpha1-antitrypsin in the general population","volume":"67","author":"Ferrarotti","year":"2012","journal-title":"Thorax"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1183\/13993003.00940-2015","article-title":"Polymers of Z alpha1-antitrypsin are secreted in cell models of disease","volume":"47","author":"Fra","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/hep.21987","article-title":"Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine","volume":"47","author":"Glantz","year":"2008","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/hep.510280421","article-title":"Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency","volume":"28","author":"Graziadei","year":"1998","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1080\/14767058.2017.1332036","article-title":"Perinatal outcomes associated with intrahepatic cholestasis of pregnancy","volume":"31","author":"Herrera","year":"2018","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1126\/science.1190354","article-title":"An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis","volume":"329","author":"Hidvegi","year":"2010","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1042\/BJ20131650","article-title":"Altered native stability is the dominant basis for susceptibility of alpha1-antitrypsin mutants to polymerization","volume":"460","author":"Irving","year":"2014","journal-title":"Biochem. J."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"570.e1","DOI":"10.1016\/j.ajog.2015.06.021","article-title":"Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy","volume":"213","author":"Kawakita","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e4949","DOI":"10.1097\/MD.0000000000004949","article-title":"Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: a meta-analysis (a prisma-compliant study)","volume":"95","author":"Kong","year":"2016","journal-title":"Medicine"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1055\/s-2008-1078756","article-title":"Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy","volume":"25","author":"Lee","year":"2008","journal-title":"Am. J. Perinatol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/1573396314666181113094517","article-title":"Alpha1-antitrypsin deficiency: transition of care for the child with AAT deficiency into adulthood","volume":"15","author":"Lin","year":"2019","journal-title":"Curr. Pediatr. Rev."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"CD012546","DOI":"10.1002\/14651858.CD012546.pub2","article-title":"Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy","volume":"7","author":"Manzotti","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1378\/chest.111.2.394","article-title":"Baseline characteristics of enrollees in the national heart, lung and blood institute registry of alpha 1-antitrypsin deficiency. Alpha 1-antitrypsin deficiency registry study group","volume":"111","author":"McElvaney","year":"1997","journal-title":"Chest"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/hep.24492","article-title":"A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart","volume":"54","author":"Miragoli","year":"2011","journal-title":"Hepatology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","article-title":"Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses","volume":"393","author":"Ovadia","year":"2019","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1080\/14767058.2018.1535588","article-title":"Assessment of fetal left ventricular modified myocardial performance index and its prognostic significance for adverse perinatal outcome in intrahepatic cholestasis of pregnancy","volume":"33","author":"Ozel","year":"2020","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1515\/jpm-2014-0207","article-title":"Can routine laboratory parameters predict adverse pregnancy outcomes in intrahepatic cholestasis of pregnancy?","volume":"43","author":"Oztas","year":"2015","journal-title":"J. Perinat. Med."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1038\/s41598-017-10812-1","article-title":"Genome-wide analysis of health-related biomarkers in the UK household longitudinal study reveals novel associations","volume":"7","author":"Prins","year":"2017","journal-title":"Sci. Rep."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbrc.2007.12.122","article-title":"Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1","volume":"367","author":"Pusl","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e28343","DOI":"10.1371\/journal.pone.0028343","article-title":"Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a northern California cohort","volume":"7","author":"Rook","year":"2012","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"550543","DOI":"10.3389\/fcell.2020.550543","article-title":"SERPINA1 gene promoter is differentially methylated in peripheral blood mononuclear cells of pregnant women","volume":"8","author":"Rotondo","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/ng.2918","article-title":"Mutations in TJP2 cause progressive cholestatic liver disease","volume":"46","author":"Sambrotta","year":"2014","journal-title":"Nat. Genet."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/lt.25057","article-title":"Heterozygosity for the alpha-1-antitrypsin Z allele in cirrhosis is associated with more advanced disease","volume":"24","author":"Schaefer","year":"2018","journal-title":"Liver Transpl."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"534.e511","DOI":"10.1053\/j.gastro.2020.04.058","article-title":"Liver phenotypes of European adults heterozygous or homozygous for pi*Z variant of AAT (pi*MZ vs pi*ZZ genotype) and noncarriers","volume":"159","author":"Schneider","year":"2020","journal-title":"Gastroenterology"},{"key":"ref37","article-title":"Alpha-1 antitrypsin deficiency,","volume-title":"GeneReviews\u00ae.","author":"Stoller","year":"1993"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1136\/gutjnl-2018-316228","article-title":"Heterozygous carriage of the alpha1-antitrypsin pi*Z variant increases the risk to develop liver cirrhosis","volume":"68","author":"Strnad","year":"2019","journal-title":"Gut"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha1-antitrypsin deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-94-007-4549-0_5","article-title":"Rapid DNA extraction protocol for detection of alpha-1 antitrypsin deficiency from dried blood spots by real-time PCR","volume":"756","author":"Struniawski","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e0200897","DOI":"10.1371\/journal.pone.0200897","article-title":"NorUDCA promotes degradation of alpha1-antitrypsin mutant Z protein by inducing autophagy through AMPK\/ULK1 pathway","volume":"13","author":"Tang","year":"2018","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/15412555.2013.765839","article-title":"Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy","volume":"10","author":"Teckman","year":"2013","journal-title":"COPD"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1042\/CS20000164","article-title":"The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterine fetal death in obstetric cholestasis","volume":"100","author":"Williamson","year":"2001","journal-title":"Clin. Sci."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1053\/j.gastro.2008.03.044","article-title":"ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults","volume":"135","author":"Ziol","year":"2008","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.720465\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T14:39:41Z","timestamp":1631025581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.720465\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,7]]},"references-count":44,"alternative-id":["10.3389\/fgene.2021.720465"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.720465","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,7]]},"article-number":"720465"}}